Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in Pulmonary Fibrosis
CY Perrot, T Karampitsakos… - American Journal of …, 2023 - journals.physiology.org
Pulmonary fibrosis results from a plethora of abnormal pathogenetic events. In idiopathic
pulmonary fibrosis (IPF), inhalational, environmental, or occupational exposures in …
pulmonary fibrosis (IPF), inhalational, environmental, or occupational exposures in …
Pulmonary fibrosis treatment in children–what have we learnt from studies in adults?
M Jia, DA Fitzgerald - Paediatric Respiratory Reviews, 2023 - Elsevier
Pulmonary fibrosis (PF) in children is a rare complication of specific forms of childhood
interstitial lung diseases (chILD) with extremely limited scientific evidence to guide optimal …
interstitial lung diseases (chILD) with extremely limited scientific evidence to guide optimal …
[HTML][HTML] Aerosol delivery in interstitial lung diseases-breakthrough or lost cause?
C Ehrhardt - Expert Opinion on Drug Delivery, 2024 - Taylor & Francis
Interstitial lung diseases (ILDs) encompass a heterogeneous group of lung disorders, each
with its own etiology, clinical presentation, and progression, characterized by inflammation …
with its own etiology, clinical presentation, and progression, characterized by inflammation …
Carole Y. Perrot1, Theodoros Karampitsakos1, Jose D. Herazo-Maya1 6 7 8 Ubben Center for Pulmonary Fibrosis Research 9 Division of Pulmonary, Critical Care …
JD Herazo-Maya - biomarkers - journals.physiology.org
Monocytes and Macrophages: Emerging Mechanisms and Novel Therapeutic Targets in
Pulmonary Fibrosis Page 1 1 2 Monocytes and Macrophages: Emerging Mechanisms and Novel …
Pulmonary Fibrosis Page 1 1 2 Monocytes and Macrophages: Emerging Mechanisms and Novel …